Bio & Pharma
Seegene's COVID-19 diagnostic product wins Product of the Year Award
The S.Korean diagnostic kit maker has developed Allplex SARS-CoV-2 Assay which detects 4 different target genes
By Dec 16, 2022 (Gmt+09:00)
1
Min read
Most Read
Samsung steps up AR race with advanced microdisplay for smart glasses
When in S. Korea, it’s a ritual: Foreigners make stops at CU, GS25, 7-Eleven
Maybe Happy Ending: A robot love story that rewrote Broadway playbook
NPS yet to schedule external manager selection; PE firms’ fundraising woes deepen
US auto parts tariffs take effect; Korea avoids heavy hit
Seegene Inc. said on Friday that its COVID-19 diagnostic product Allplex SARS-CoV-2 Assay received the Product of the Year Award at the BioSpectrum Asia Excellence Awards on Dec 2.
BioSpectrum Asia is a media platform and market research firm that covers the pharmaceutical and biotech industries in the region.
"We will contribute to the healthy life of mankind by strengthening R&D to enable faster and more accurate diagnosis of infectious diseases and genetic diseases, and widening the range of molecular diagnostics by producing excellent products," said Seegene CEO Chun Jong-Yoon.
"As a global leader in molecular diagnostics, we will continue to monitor and respond to future pandemics," he added.
In addition, Lunit, a Seoul-based medical AI company, received the Startup of the Year award.
Write to Jeong Min Nam at peux@hankyung.com
More to Read
-
-
BiotechSeegene develops one-stop COVID-19 testing lab on wheels; eyes MENA expansionJun 25, 2021 (Gmt+09:00)
2 Min read -
Comment 0
LOG IN